1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-107818
    4-Hydroxychalcone Inhibitor 99.73%
    4-Hydroxychalcone 是查尔酮代谢物,具有抗血管生成和消炎作用。 4-Hydroxychalcone 通过抑制生长因子途径抑制血管生成,无细胞毒性迹象。4-Hydroxychalcone 抑制 TNF-α 诱导的 NF-κB 途径活化并激活 BMP 信号传导,通过减轻小鼠的醛固酮过多症和肾脏损伤来降低抵抗性高血压 (RH)。
    4-Hydroxychalcone
  • HY-N0492S
    α-Lipoic Acid-d5

    α-硫辛酸 d5

    Inhibitor
    α-Lipoic Acid-d5 是 α-Lipoic Acid 的氘代物。α-Lipoic Acid 是一种抗氧化剂,是线粒体酶复合物的重要辅助因子。α-Lipoic Acid 可抑制 NF-κB 依赖性的 HIV-1 LTR 活化。α-Lipoic Acid 诱导内质网应激 (ERS) 介导的肝癌细胞凋亡 (apoptosis)。
    α-Lipoic Acid-d<sub>5</sub>
  • HY-B0289
    Erdosteine

    厄多司坦

    Inhibitor 99.62%
    Erdosteine 抑制脂多糖 (LPS) 诱导的 NF-κB 激活。Erdosteine 具有粘液调节,抗菌,抗炎和抗氧化作用。
    Erdosteine
  • HY-B0130
    Perindopril

    培哚普利

    98.01%
    Perindopril erbumine 是一种血管紧张素转换酶 (angiotensin-converting enzyme) 抑制剂,调节NF-κB 和 STAT3 信号传导,抑制胶质细胞活化和神经炎症,可用于慢性肾脏病和高血压的研究。
    Perindopril
  • HY-17630
    Edasalonexent Inhibitor 99.17%
    Edasalonexent (CAT-1004) 是一种可口服利用的 NF-κB 抑制剂。
    Edasalonexent
  • HY-131670
    (±)9,10-DiHOME Activator 99.90%
    (±)9,10-DiHOME 是 9,10-DiHOME 的消旋体。9,10-DiHOME 是亚油酸二醇的白细胞毒素衍生物,据报道在人体组织制剂中有毒,由中性粒细胞和巨噬细胞等炎症白细胞产生。
    (±)9,10-DiHOME
  • HY-141645
    IMM-H007 Inhibitor
    IMM-H007 (WS070117) 是一种口服有效的 AMPK (AMP 活化蛋白激酶) 激活剂和 TGFβ1 (转化生长因子 β1) 拮抗剂。 IMM-H007 通过激活 AMPK (AMP 活化蛋白激酶)对心血管疾病具有保护作用。 IMM-H007 通过失活 NF-κBJNK/AP1 信号通路负向调节内皮细胞炎症反应。IMM-H007 抑制 ABCA1 的降解。 IMM-H007 通过调节脂质代谢来解决高脂饮食喂养的仓鼠的肝脏脂肪变性。IMM-H007 可用于非酒精性脂肪肝 (NAFLD) 和炎性动脉粥样硬化的研究。
    IMM-H007
  • HY-148877
    AT-533 Inhibitor 98.86%
    AT-533 是一种有效的 Hsp90HSV 抑制剂。AT-533 通过阻断 HIF-1α/VEGF/VEGFR-2 信号通路抑制肿瘤生长和血管生成。AT-533 还抑制下游通路的激活,包括 Akt/mTOR/p70S6K, Erk1/2FAK。AT-533 抑制人脐静脉内皮细胞 (HUVEC) 的管形成、细胞迁移和侵袭。
    AT-533
  • HY-A0068
    Aurothioglucose

    金硫葡萄糖

    Inhibitor
    Aurothioglucose (Gold thioglucose) 含有单价金离子,是一种有效的 TrxR1 (硫氧还蛋白还原酶 1) 的活性位点抑制剂,其 IC50 为 65 nM。Aurothioglucose 在体外抑制 NF-κB 的 DNA 结合。Aurothioglucose 具有抗 HIV 和抗风湿的活性。
    Aurothioglucose
  • HY-118828
    12-Oxo phytodienoic acid 99.57%
    12-Oxo phytodienoic acid (12-OPDA) 是一种植物脂质衍生的抗炎症化合物。12-Oxo phytodienoic acid 通过抑制被脂多糖 (LPS) 激活的细胞中 Nf-κBp38 MAPK 信号传导来抑制神经炎症。12-Oxo phytodienoic acid 可用于神经退行性疾病的研究。
    12-Oxo phytodienoic acid
  • HY-121410
    Narasin

    甲基盐霉素

    Inhibitor ≥98.0%
    Narasin 是一种阳离子离子载体和抗球虫药。Narasin 抑制 NF-κB 信号传导并诱导肿瘤细胞凋亡 (apoptosis),具有抗微生物和抗癌活性。
    Narasin
  • HY-N6946
    Mitraphylline

    帽柱叶碱

    99.68%
    Mitraphylline 是绒毛钩藤中主要的五环吲哚类生物碱。Mitraphylline 能抑制脂多糖介导的原代人中性粒细胞活化。
    Mitraphylline
  • HY-N0460
    1-Caffeoylquinic acid Inhibitor 99.06%
    1-Caffeoylquinic acid 1-咖啡酰奎宁酸是一种有效的 NF-κB 抑制剂,对 p105 的 RH 结构域显示高结合亲和力,Ki 值为 0.002 μM,结合能为 1.50 Kcal/mol。1-Caffeoylquinic acid 具有抗氧化应激能力。 1-Caffeoylquinic acid 抑制 PD-1/PD-L1 相互作用。
    1-Caffeoylquinic acid
  • HY-N2477
    Taraxerol Inhibitor 98.79%
    Taraxerol 是从蒲公英中分离出来的,具有抗炎和抗癌作用。Taraxerol 通过抑制 NF-κB 信号通路来减轻急性炎症。Taraxerol 诱导细胞凋亡 (apoptosis)。
    Taraxerol
  • HY-119720
    Neocryptotanshinone

    新隐丹参酮

    Inhibitor 98.82%
    Neocryptotanshinone 是从丹参 (Salvia Miltiorrhiza) 分离得到的一种丹参二萜,通过抑制 NF-κBiNOS 信号来抑制脂多糖 (LPS) 诱导的炎症。
    Neocryptotanshinone
  • HY-N0392
    Polygalasaponin F

    瓜子金皂苷己

    Inhibitor 99.85%
    Polygalasaponin F 是一种从 Polygala japonica 提取的齐墩果烷型三萜皂苷,可降低炎性细胞因子肿瘤坏死因子 α (TNFa) 的释放。 Polygalasaponin F 通过调节 TLR4-PI3K/AKT-NF-kB 信号通路减少神经炎症细胞因子的分泌。
    Polygalasaponin F
  • HY-N2453
    Convallatoxin

    铃兰毒苷

    Inhibitor 98.66%
    Convallatoxin 是从 Adonis amurensis Regel et Radde 分离得到的强心苷。Convallatoxin 通过激活 PPARγ 和抑制 NF-κB 改善结肠炎。Convallatoxin 是一种 P-糖蛋白 (P-gp) 底物,并识别 Val982 是参与其转运的重要氨基酸。Convallatoxin 是配体诱导的 MOR 胞吞作用的增强剂,具有很高的效力和功效。具有抗炎和抗增殖特性。
    Convallatoxin
  • HY-N2995
    Poricoic acid A

    茯苓新酸 A

    Modulator 98.08%
    Poricoic acid A从Poria cocos 中提取得到,拥有抗肿瘤活性。Poricoic acid A 可通过调节Gas6/AxlNFκB/Nrf2 轴增强AKI-to-CKD 的褪黑激素抑制。
    Poricoic acid A
  • HY-N6826
    Asatone

    细辛酮

    Activator 99.94%
    Asatone 是从细辛中分离到的一种活性成分,具有抗炎活性,通过活化 NF-κB 及下调 p-MAPK (ERKJNK 和 p38) 通路起作用。
    Asatone
  • HY-101402A
    Cyclo(his-pro) TFA Inhibitor 99.13%
    Cyclo(his-pro) TFA (Cyclo(histidyl-proline) TFA) 是一种具有口服活性的,结构上与促甲状腺激素释放激素相关的环状二肽。Cyclo(his-pro) TFA 可以抑制 NF-κB 核积累。Cyclo(his-pro) TFA 可以穿越脑血屏障并影响多种炎症和应激反应。
    Cyclo(his-pro) TFA
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.